1. Home
  2. SBFM vs FTEL Comparison

SBFM vs FTEL Comparison

Compare SBFM & FTEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SBFM
  • FTEL
  • Stock Information
  • Founded
  • SBFM 2006
  • FTEL 2007
  • Country
  • SBFM United States
  • FTEL Australia
  • Employees
  • SBFM N/A
  • FTEL N/A
  • Industry
  • SBFM Biotechnology: Pharmaceutical Preparations
  • FTEL
  • Sector
  • SBFM Health Care
  • FTEL
  • Exchange
  • SBFM Nasdaq
  • FTEL Nasdaq
  • Market Cap
  • SBFM 4.9M
  • FTEL N/A
  • IPO Year
  • SBFM N/A
  • FTEL 2023
  • Fundamental
  • Price
  • SBFM $1.25
  • FTEL $0.64
  • Analyst Decision
  • SBFM Strong Buy
  • FTEL
  • Analyst Count
  • SBFM 1
  • FTEL 0
  • Target Price
  • SBFM $15.00
  • FTEL N/A
  • AVG Volume (30 Days)
  • SBFM 3.7M
  • FTEL 150.5K
  • Earning Date
  • SBFM 05-19-2025
  • FTEL 04-29-2025
  • Dividend Yield
  • SBFM N/A
  • FTEL N/A
  • EPS Growth
  • SBFM N/A
  • FTEL N/A
  • EPS
  • SBFM N/A
  • FTEL N/A
  • Revenue
  • SBFM $34,874,283.00
  • FTEL $4,466,775.00
  • Revenue This Year
  • SBFM $192.48
  • FTEL N/A
  • Revenue Next Year
  • SBFM N/A
  • FTEL N/A
  • P/E Ratio
  • SBFM N/A
  • FTEL N/A
  • Revenue Growth
  • SBFM 44.75
  • FTEL N/A
  • 52 Week Low
  • SBFM $1.19
  • FTEL $0.51
  • 52 Week High
  • SBFM $91.40
  • FTEL $49.50
  • Technical
  • Relative Strength Index (RSI)
  • SBFM 27.96
  • FTEL 34.07
  • Support Level
  • SBFM $1.36
  • FTEL $0.61
  • Resistance Level
  • SBFM $1.65
  • FTEL $0.70
  • Average True Range (ATR)
  • SBFM 0.31
  • FTEL 0.07
  • MACD
  • SBFM -0.04
  • FTEL 0.11
  • Stochastic Oscillator
  • SBFM 2.97
  • FTEL 49.31

About SBFM Sunshine Biopharma Inc.

Sunshine Biopharma Inc is a pharmaceutical company offering and researching life-saving medicines in a wide variety of therapeutic areas, including oncology and antivirals. Through its subsidiaries, the company has various generic prescription drugs on the market in Canada and is also involved in developing and selling OTC supplements. In addition, the company is conducting a proprietary drug development program, which is comprised of K1.1 mRNA targeted for liver cancer and SBFM-PL4, PLpro protease inhibitor for SARS Coronavirus infections.

Share on Social Networks: